Currently Available Clinical Trials from Georgetown Lombardi
There are currently no clinical trials for gynecological cancer available at Georgetown Lombardi.
More clinical trials are available on NIH’s national clinical trial database.
For appointments and information, call (202) 360-8613.
You will be redirected to our clinical partner, MedStar Health.
About the Cancer
Georgetown Lombardi is committed to providing the best professional care, delivered with compassion, for all patients and to provide you with the most current gynecologic health information and resources. Along with cutting-edge cancer care, we offer a program of innovative clinical trials and a full range of supportive care services to improve our patients’ health and quality of life.
Current information about gynecologic cancers (ovarian, cervical, endometrial, and more), incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research, are available online from the National Cancer Institute at the National Institutes of Health.
What We Offer
The Georgetown Lombardi Comprehensive Cancer Center, division of Gynecologic Oncology, provides comprehensive, multidisciplinary treatment for women with gynecologic malignancies (including, but not limited to Ovarian, Cervical, Endometrial). Services include evaluation and treatment of both pre-cancerous as well as cancerous conditions of the cervix, uterus, ovaries, and vulva. Treatment modalities can include surgery, chemotherapy, or radiation; all administered under the direction of the experienced, board certified Gynecologic Oncologist.
- Gynecologic Cancer Care Services at MedStar Health
- Patient and Family Resources
- Clinical Trials. With our clinical partner, MedStar Health, Georgetown Lombardi is pleased to offer you access to cutting-edge clinical trials.
Georgetown Lombardi’s world-renowned research faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow — targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.